Postgraduate in the field of Life Sciences or Pharmaceutical Sciences or any other allied Life sciences. Exploiting synthetic lethality of type II NADH dehydrogenases for complete sterilization of Mycobacterium tuberculosis
List of the following vacancies on contract basis for the newly started Sembatti Primary Health Center (Aruppukkottai area) and Ilupbaiyur Primary Health Centers (Narikudi area) in Virudhunagar district.
M.Sc. (Life Sciences: Biochemistry, Biotechnology, or any branch of Life Sciences) degree holders. OR MBBS/BDS/MS Pharm/M. Pharma/ME/M. Tech degree holders.
First class PharmD / M.Pharm in Pharmacy Practice specialization, with PhD Degree in respective field. Candidates who are about to complete PhD may also apply.
M. Pharm. or M.S. Pharm. or M. Sc. with 1 year research experience or M. Tech. Strong Python programming skills with hands-on experience of using scientific Python libraries.
Project Research Scientist-I under ICMR- funded project titled Evaluation of novel dipstick based molecular techniques for early detection of Gram- negative ESKAPE organisms and antimicrobial resistance genes in bum wounds.
Master of Pharmacy Participation in Investigations, Root cause analysis and proposing relevant CAPAs against OOS: OOT: incident, and change control complaints and audit observations to QMS team.
Hetero is one of worlds leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140 countries and backed by 30 years of experience in the pharma sector.
Responsible for designing overall marketing and communication strategy of brands Good at Sales & Market data analysis. Must possess knowledge of product strategy, product launch
The U.S. Food and Drug Administration has approved Cablivi (caplacizumab-yhdp) for pediatric patients 12 years and older suffering from acquired thrombotic thrombocytopenic purpura (aTTP), marking the first time a treatment has been authorized for this extremely rare condition in children.
ScinoPharm Taiwan has clinched a landmark regulatory victory by securing U.S. Food and Drug Administration (FDA) approval for its Glatiramer Acetate Injection, a treatment used to manage multiple sclerosis (MS), the company announced
Dispense prescribed medications accurately and efficiently to patients. Review and verify prescriptions for dosage, drug interactions, and contraindications.